Irtiza N. Sheikh, DO, hopes liso-cel accessibility increases in non-clinical trial settings and is considered for use earlier in the LBCL treatment course.
Irtiza N. Sheikh, DO
Advertisement
Articles by Irtiza N. Sheikh, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts Topical Gel sNDA for Superficial Basal Cell Carcinoma
2
Advances in Immunotherapy for Breast Cancer
3
Phase 2b Prostate Cancer Study Receives FDA Clearance in High-Risk Groups
4
Tandem 2026: Key Advances in Cellular Therapy and Transplantation
5